Lang Li, PhD

AI-Enhanced Maternal and Pediatric Precision Therapy (MPRINT) Knowledgebases

Anna E. Patrick, MD, PhD

Biologic Medications in Autoimmune Disease

Laura Ramsey, PhD

Pharmacogenetic influences on sertraline exposure and tolerability in children and adolescents

Dr. Sara Quinney & Dr. Robert Bies

*Pharmacometric Modeling in Pregnancy and Lactation

Dr. Barrett & Dr. Standing

Ask Me Anything!

Dr. Tamorah Lewis

University of Toronto &SickKids

The Intersection of Ontogeny, Pharmacogenetics and Drug Safety in the NICU

Dr. Sara Quinney, Dr. Adriana Tremoulet, & Dr. Prince Kannankeril

*MPRINT 101:MPRINT Information, Resources, and Support

Dr. Jun Yung

*Pharmacogenomics of Drug Toxicity and its Clinical Implementation

Monika Grabowska, MS

MD/PhD Candidate

Pediatric Phecodes for Electronic Health Records Phenotyping

Dr. Christopher Parshuram

*Pharmacotherapy of Pediatric Critical Care

Dr. Heather Mefford, St. Jude Children's Research Hospital

"From gene discovery to targeted therapy in severe pediatric epilepsies"

Dr. Kelly Caudle

St. Jude Children's Research Hospital

CPIC: Facilitating the implementation of pharmacogenomics through global collaboration

Gretchen Bandoli, PhD

Acetaminophen in pregnancy and childhood neurodevelopment weighing the evidence

Sara Van Driest, MD, PhD

Tips for Preparing and Delivering Scientific Talks

Anna Patrick, MD, PhD

Deciphering the Genetic Contributions to Gene Expression in Juvenile Idiopathic Arthritis

James Antoon, MD, PhD, MPH

Oseltamivir and Prevalence of Concurrent Medications with Drug-Drug Interactions

Ashley Leech, PhD, MS

Late maternal dead and overdose among pregnant individuals vulnerable to opioid use disorder and with OUD during pregnancy

Miranda Kiefer, DO

Frequency and dosing of Nifedipine in women with severe pre-eclampsia undergoing expectant management

Kara Rood, MD

Using exosomes as a pharmacodynamic endpoint to determine aspirin dosing for the prevention of preeclampsia: a pilot proof of concept study

Lars Bode, PhD

Developing therapeutics and diagnostics for NEC based on human milk

Victor Nizet, MD

Responding to Reviewers

William J Jusko, PhD

Application of Minimum PBPK Models to Meta-Assessment of Dexamethasone and Betamethasone During Pregnancy

André Dallmann, PharmD, PhD

Postpartum amoxicillin PBPK Model

Prince Kannankeril, MD, MSCI

Postpartum Medicine in Pediatric Cardiology

Elizabeth Jasper, PhD

Biosketch Clinic

Blessed Winston Arul Dhas, MD

Population pharmacokinetics of Methadone and Oxycodone in children undergoing major surgeries

Emma M. Tillman, Pharm.D. Ph.D

Building and leading your research team

Andrew D. Wiese, MPH, PhD

Leveraging real-world data to inform the safe prescribing of opioids in the postpartum period

Sara K. Quinney, PharmD, PhD

NCA? PopPK? PBPK? How do I know when to use what method?

Shirley M. Tsunoda, PharmD

Pieter C. Dorrestein, PhD

Advances in Molecular Pharmacology with Untargeted Metabolomics-intro to untargeted metabolomics for MPRINT

Dr. Peter Schwartz, et al.

Bioethics Roundtable

Julia C. Phillippi PhD, CNM, FACNM

The Power of Maternal Characteristics on Perinatal Outcomes: Potential Confounders for Perinatal Investigations

Lars Bode, PhD

Christina Chambers, PhD, MPH

Human Milk at the Intersection of Maternal and Pediatric Therapeutics

Sara Van Driest, MD, PhD

Using Real World Electronic Health Records Data for Precision Medicine Research

Rob Bies, PhD, PharmD, BSC

An Introduction to Model Informed Drug Development